Cochrane Renal Group

 Back
autoid 88
crg_id CRG120500025
titleoftrial EXPANSION OF BLOOD VOLUME INCREASE PATENCY RATE OF PRIMARY ARTERIOVENOUS FISTULAS (AVF) IN PATIENTS WITH CRITICAL QUALLITY OF VESSELS
acronymnoftrial Arteriovenous fistula patency and blood volume
website http://
identificationno Grant number: L3-4486-0312 and P3-0323-0312
leadprefix Prof
leadsurname Malovrh
leadgivennames Marko
leadposition Head of Center for haemodialysis
leaddepartment Department of Nephrology
leadorganisation University Medical Center Ljubljana
leadaddress Zaloska 7, Ljubljana, 1525, Slovenia
leademail marko.malovrh@kclj.si
leadphone +386 1 5222941
leadfax +386 1 5222460
leadsuffix
contactprefix
contactsurname
contactgivennames
contactposition
contactdepartment
contactorganisation
contactaddress
contactemail
contactphone
contactfax
funding govt
otherfunding
fundingnameofsponsors
ethicsapproval yes
studytype randomised
studytype_other
groupassignment parallel
blinding_patients no
blinding_investigators no
blinding_outcomes no
blinding_analysts no
proposedstart 09/1999
actualstart
proposedcompletiondate
actualcompletiondate 12/2003
multi_center_study no
numberofcentres
multi_national_study no
countrycentres Slovenia
researchquestion The purpose of this prospective study was to find out if blood volume expansion and consequently increased flow through the feeding artery can prevent early arteriovenous fistula function in the risk group of patients.
study_status_recruitment no_longer_recruiting
study_status_recruitment_follow completed
healthcarecondition chronic renal failure
intervention1 Hemohes 6%, Braun, Melsungen, Germany
intervention2
intervention3
intervention4
participants_gender both
participants_other both
age older than 18 years
totalrecruitment 120
inclusion 1. dialysis and pre-dialysis patients
2. internal diameter of feeding artery =< 1.6 mm
3. resistance index at reactive hyperemia by duplex ultrasound > 0.7
exclusion 1. internal diameter of feeding artery > 1.6 mm
2. resistance index at reactive hyperemia by
duplex ultrasound < 0.7
primaryoutcomes primary patency rate of arteriovenous fistula
secondaryoutcomes long-term arteriovenous fistula usefulness for haemodialysis treatment
reference 1. Malovrh M. Native arteriovenous fistula. Preoperative evaluation. Am J Kidney Dis 2002; 39:1118-1125.
2. Owada A, Saito H, Mochizuki T, et al. Radial artery spasm in uremic patients undergoing construction of arterial hemodialysis fistulas: diagnosis and prophylaxis with intravenous nicardipine. Nephron 1993;64:37-41.
3. Owada A, Saito H, Nagai T, Iwamoto H, Shigai T. Prophylactic use of intravenous prostaglandin E1 for radial arterial spasm in uremic patients undergoing construction of arteriovenous hemodialysis fistulas. Int J Artif Organs 1994;17:511-4.
4. Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA.The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg. 2001 Jun;92(6):1402-7.